Pharmacokinetics and drug therapy in neonates

Neonates include both full term and preterm infants up to 28 days of age. The heterogeneity and rapid physiologic change of neonates affect all aspects of pharmacokinetics such as absorption, distribution, metabolism, and elimination. This feature should be considered in determining the dose and reg...

Full description

Bibliographic Details
Main Author: Hye Jung Cho
Format: Article
Language:English
Published: Korean Society of Pediatric Emergency Medicine 2017-06-01
Series:Pediatric Emergency Medicine Journal
Subjects:
Online Access:http://pemj.org/upload/pdf/pemj-2017-00059.pdf
_version_ 1797852263645970432
author Hye Jung Cho
author_facet Hye Jung Cho
author_sort Hye Jung Cho
collection DOAJ
description Neonates include both full term and preterm infants up to 28 days of age. The heterogeneity and rapid physiologic change of neonates affect all aspects of pharmacokinetics such as absorption, distribution, metabolism, and elimination. This feature should be considered in determining the dose and regimen of drug therapy in neonates. However, the research on the safety and efficacy of specific drugs is limited due to ethical and technical issues. This review article focuses on the neonatal pharmacokinetics and the rationales of drug therapy in neonates based on findings of previous studies and empirical evidence.
first_indexed 2024-04-09T19:31:14Z
format Article
id doaj.art-a38b9c832c3a4e06974ac9df1e3e7f84
institution Directory Open Access Journal
issn 2383-4897
2508-5506
language English
last_indexed 2024-04-09T19:31:14Z
publishDate 2017-06-01
publisher Korean Society of Pediatric Emergency Medicine
record_format Article
series Pediatric Emergency Medicine Journal
spelling doaj.art-a38b9c832c3a4e06974ac9df1e3e7f842023-04-04T23:44:02ZengKorean Society of Pediatric Emergency MedicinePediatric Emergency Medicine Journal2383-48972508-55062017-06-014151110.22470/pemj.2017.0005944Pharmacokinetics and drug therapy in neonatesHye Jung Cho0Department of Pediatrics, Gachon University College of Medicine, Incheon, KoreaNeonates include both full term and preterm infants up to 28 days of age. The heterogeneity and rapid physiologic change of neonates affect all aspects of pharmacokinetics such as absorption, distribution, metabolism, and elimination. This feature should be considered in determining the dose and regimen of drug therapy in neonates. However, the research on the safety and efficacy of specific drugs is limited due to ethical and technical issues. This review article focuses on the neonatal pharmacokinetics and the rationales of drug therapy in neonates based on findings of previous studies and empirical evidence.http://pemj.org/upload/pdf/pemj-2017-00059.pdfbronchiolitisdrug administration routesdrug therapyinfantsnewbornpharmacokinetics
spellingShingle Hye Jung Cho
Pharmacokinetics and drug therapy in neonates
Pediatric Emergency Medicine Journal
bronchiolitis
drug administration routes
drug therapy
infants
newborn
pharmacokinetics
title Pharmacokinetics and drug therapy in neonates
title_full Pharmacokinetics and drug therapy in neonates
title_fullStr Pharmacokinetics and drug therapy in neonates
title_full_unstemmed Pharmacokinetics and drug therapy in neonates
title_short Pharmacokinetics and drug therapy in neonates
title_sort pharmacokinetics and drug therapy in neonates
topic bronchiolitis
drug administration routes
drug therapy
infants
newborn
pharmacokinetics
url http://pemj.org/upload/pdf/pemj-2017-00059.pdf
work_keys_str_mv AT hyejungcho pharmacokineticsanddrugtherapyinneonates